Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
03.11.23
/
50%
€51.30
Target price
03.11.24
€94.07
Performance (%)
28.66%
Price
27.08.24
€66.50
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald currently has a performance of 28.66%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -2.920% | -2.920% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Cantor Fitzgerald from $98.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
08.08.24
08.08.24
€119.16
08.08.25
08.08.25
-2.92%
27.08.24
27.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
14.06.24
14.06.24
€112.19
14.06.25
14.06.25
4.72%
27.08.24
27.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
24.04.24
24.04.24
€112.30
24.04.25
24.04.25
-2.92%
27.08.24
27.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€93.28
23.02.25
23.02.25
2.62%
27.08.24
27.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
11.95%
27.08.24
27.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€80.23
29.03.24
29.03.24
22.14%
30.03.24
30.03.24